Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nestle To Become No. 1 In China's Infant Formula Market Following Pfizer Nutrition Acquisition

Apr 27 2012

• By Jialing Dai

Related Content

Pfizer Nutrition Continues Launches Despite Divestment Possibility

May 02 2011

Pfizer Sells Nutrition Portfolio To Nestle For Nearly $12B

Apr 23 2012

Novartis Tagged With Anti-monopoly Conditions In China For Alcon Acquisition

Aug 17 2010

Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth

Jun 01 2010

Insider Analysis From Sidley Austin LLP: Getting Ready For China’s Anti-Monopoly Law

Apr 12 2008

More Barriers To Entry For M&A In China? Novartis Case Provides Some Clarity

Oct 19 2011

China Passes Food Safety Law Following Melamine Infant Formula Disasters

Mar 05 2009

Related Companies

Nestle Health Science

Pfizer Inc.

Mead Johnson Nutrition Co.

Danone SA

Abbott

Novartis AG

Novartis AG

Additional Topics

China Asia Pacific Emerging Markets Deals OTC Drugs Consumer

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window